Inflammatory cells infiltrate and angiogenesis in locally advanced and metastatic cholangiocarcinoma

被引:34
|
作者
Tamma, Roberto [1 ]
Annese, Tiziana [1 ]
Ruggieri, Simona [1 ]
Brunetti, Oronzo [2 ]
Longo, Vito [2 ]
Cascardi, Eliano [3 ]
Mastropasqua, Mauro Giuseppe [3 ]
Maiorano, Eugenio [3 ]
Silvestris, Nicola [2 ]
Ribatti, Domenico [1 ]
机构
[1] Univ Bari, Med Sch, Dept Basic Med Sci Neurosci & Sensory Organs, Bari, Italy
[2] Canc Inst Giovanni Paolo II, Med Oncol Unit, Bari, Italy
[3] Univ Bari, Med Sch, Pathol Sect, Dept Emergency & Organ Transplantat DETO, Bari, Italy
关键词
angiogenesis; cholangiocarcinoma; lymphocytes; macrophages; mast cells; tumour progression; ENDOTHELIAL GROWTH-FACTOR; EXPRESSION; MACROPHAGES; CARCINOMA; PROGNOSIS; DENSITY; VEGF;
D O I
10.1111/eci.13087
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cholangiocarcinoma (CCA) is the second most common subtype of primary hepatobiliary cancer and one of the most aggressive characterized by an extremely poor prognosis with limited treatment options. Inflammatory cells in tumour microenvironment support tumour growth in term of progression, angiogenesis and metastatic capacity. A link between inflammation and biliary carcinogenesis has been previously observed but the mechanisms involved remain to be determined. Methods: We investigated the microvascular density (MVD) and inflammatory cells in tissue samples from 40 patients with CCA with locally advanced CCA and metastatic CCA by means of immunohistochemical analysis of macrophages, mast cells, B and T lymphocytes and we correlated inflammatory infiltrate with MVD. Results: We observed significant decrease in the levels of CD31 positive vessels, and CD8, CD4, CD68 and tryptase-positive cells in metastatic lesions as compared to the localized ones. A negative correlation between CD31 and CD8 and CD31 and CD4 in localized CCA samples was found as assessed by Spearman correlation analysis. Conclusions: In locally advanced CCA patients, there is a significant increase of immune cell infiltrate constituted by CD8(+) and CD4(+) lymphocytes, macrophages and mast cells as compared to the metastatic ones. This alteration in the tumour microenvironment infiltrate is related to a significant increased MVD in localized CCA lesions compared with the metastatic ones. Moreover, we observed a negative correlation between MVD and CD8(+), CD4(+) cells in localized CCA patients.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Systemic Therapy for Locally Advanced and Metastatic Cholangiocarcinoma
    Sookprasert, Aumkhae
    Chindaprasirt, Jarin
    Wirasorn, Kosin
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 : 3 - 6
  • [2] Futibatinib: A Review in Locally Advanced and Metastatic Cholangiocarcinoma
    Hoy, Sheridan M.
    [J]. TARGETED ONCOLOGY, 2024, 19 (03) : 473 - 480
  • [3] Management of Locally Advanced or Metastatic Combined Hepatocellular Cholangiocarcinoma
    Zhao, Jemmy
    Stephan-Falkenau, Susann
    Schuler, Markus
    Arndt, Boerge
    [J]. CANCERS, 2023, 15 (03)
  • [4] Inflammatory Infiltrate and Angiogenesis in Mantle Cell Lymphoma
    Annese, Tiziana
    Ingravallo, Giuseppe
    Tamma, Roberto
    De Giorgis, Michelina
    Maiorano, Eugenio
    Perrone, Tommasina
    Albano, Francesco
    Specchia, Giorgina
    Ribatti, Domenico
    [J]. TRANSLATIONAL ONCOLOGY, 2020, 13 (03):
  • [5] Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma - an Austrian expert consensus statement
    Taghizadeh, Hossein
    Djanani, Angela
    Eisterer, Wolfgang
    Gerger, Armin
    Gruenberger, Birgit
    Gruenberger, Thomas
    Rumpold, Holger
    Weiss, Lukas
    Winder, Thomas
    Woell, Ewald
    Prager, Gerald W.
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [6] Chemoradiation for locally advanced perihilar cholangiocarcinoma
    Lim, Seungtaek
    Choi, Hye Jin
    Seong, Jinsil
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [7] Conditional probability of long-term survival in patients with locally advanced and metastatic hilar cholangiocarcinoma
    Gaspersz, M.
    Buettner, S.
    van Vugt, J.
    Roos, E.
    Coelen, R.
    van Gulik, T.
    IJzermans, J.
    Koerkamp, B. G.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S446 - S447
  • [8] Pemigatinib for previously treated locally advanced/metastatic cholangiocarcinoma (CCA): Update of FIGHT-202.
    Abou-Alfa, Ghassan K.
    Sahai, Vaibhav
    Hollebecque, Antoine
    Vaccaro, Gina M.
    Melisi, Davide
    Al-Rajabi, Raed Moh'd Taiseer
    Paulson, Andrew Scott
    Borad, Mitesh J.
    Gallinson, David H.
    Murphy, Adrian Gerard
    Oh, Do-Youn
    Dotan, Efrat
    Catenacci, Daniel
    Van Cutsem, Eric
    Lihou, Christine Francis
    Zhen, Huiling
    Feliz, Luis
    Vogel, Arndt
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Capecitabine (X) single-agent therapy in patients (pts) with locally advanced/metastatic cholangiocarcinoma
    Sew, O. Sea
    Sookprasert, A.
    Bhudhisawad, V.
    Kaewket, V.
    Pirojkul, C.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 53 - 54
  • [10] Neoadjuvant concurrent chemoradiotherapy in locally or locally advanced hilar cholangiocarcinoma
    Lee, Hyun Jik
    Lee, Hee Seung
    Lee, Sang Hoon
    Chung, Moon Jae
    Park, Jeong Youp
    Park, Seung Woo
    Song, Si Young
    Chung, Jae Bok
    Bang, Seungmin
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 78 - 78